Table 1

Demographic data of the study patients

All patientsAF groupSR group
Number815028
Age (years)69 ± 969 ± 869 ± 11
Sex (%male)646264
Prior cardioversions0.2 ± 0.50.2 ± 0.50.3 ± 0.5
Aetiology* (%)MVD 23, BP 44, IHD 21, ALC 6, DCM 1, LONE 36MVD 28, BP 42, IHD 18, ALC 8, DCM 2, LONE 34MVD 18, BP 46, IHD 25, ALC 4, LONE 39
AF duration (months)12 ± 2214 ± 259 ± 18
LA size (mm)45 ± 744 ± 645 ± 8
FS (%)32 ± 931 ± 1032 ± 9
SSS1064
All patientsAF groupSR group
Number815028
Age (years)69 ± 969 ± 869 ± 11
Sex (%male)646264
Prior cardioversions0.2 ± 0.50.2 ± 0.50.3 ± 0.5
Aetiology* (%)MVD 23, BP 44, IHD 21, ALC 6, DCM 1, LONE 36MVD 28, BP 42, IHD 18, ALC 8, DCM 2, LONE 34MVD 18, BP 46, IHD 25, ALC 4, LONE 39
AF duration (months)12 ± 2214 ± 259 ± 18
LA size (mm)45 ± 744 ± 645 ± 8
FS (%)32 ± 931 ± 1032 ± 9
SSS1064

MVD, mitral valve disease; BP, hypertension; IHD, ischaemic heart disease; ALC, alcohol; DCM, dilated cardiomyopathy; SSS, sick sinus syndrome; LA, left atrium; FS, fractional shortening. NB: 3 patients lost to follow-up and therefore not classified.

Table 1

Demographic data of the study patients

All patientsAF groupSR group
Number815028
Age (years)69 ± 969 ± 869 ± 11
Sex (%male)646264
Prior cardioversions0.2 ± 0.50.2 ± 0.50.3 ± 0.5
Aetiology* (%)MVD 23, BP 44, IHD 21, ALC 6, DCM 1, LONE 36MVD 28, BP 42, IHD 18, ALC 8, DCM 2, LONE 34MVD 18, BP 46, IHD 25, ALC 4, LONE 39
AF duration (months)12 ± 2214 ± 259 ± 18
LA size (mm)45 ± 744 ± 645 ± 8
FS (%)32 ± 931 ± 1032 ± 9
SSS1064
All patientsAF groupSR group
Number815028
Age (years)69 ± 969 ± 869 ± 11
Sex (%male)646264
Prior cardioversions0.2 ± 0.50.2 ± 0.50.3 ± 0.5
Aetiology* (%)MVD 23, BP 44, IHD 21, ALC 6, DCM 1, LONE 36MVD 28, BP 42, IHD 18, ALC 8, DCM 2, LONE 34MVD 18, BP 46, IHD 25, ALC 4, LONE 39
AF duration (months)12 ± 2214 ± 259 ± 18
LA size (mm)45 ± 744 ± 645 ± 8
FS (%)32 ± 931 ± 1032 ± 9
SSS1064

MVD, mitral valve disease; BP, hypertension; IHD, ischaemic heart disease; ALC, alcohol; DCM, dilated cardiomyopathy; SSS, sick sinus syndrome; LA, left atrium; FS, fractional shortening. NB: 3 patients lost to follow-up and therefore not classified.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close